PREVALENCE, DIAGNOSIS, AND TREATMENT OF IMPAIRED FASTING GLUCOSE AND IMPAIRED GLUCOSE TOLERANCE

Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in patients with thalassemia major in Iran: A meta-analysis

Background: This study aimed to investigate the prevalence of diabetes, impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) in Iranian patients with thalassemia major. Methods: The current study has been conducted based on PRISMA guideline. To obtain the documents, Persian and English scientific databases such as Magiran, Iranmedex, SID, Medlib, IranDoc, Scopus, PubMed, Scien...

Prevalence, Diagnosis, and Treatment of Impaired Fasting Glucose and Impaired Glucose Tolerance in Nondiabetic U.S. Adults

OBJECTIVE To estimate the rates of prevalence, diagnosis, and treatment of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT). RESEARCH DESIGN AND METHODS A representative sample of the U.S. population (the National Health and Nutrition Examination Survey [NHANES]) from 2005-2006 including 1,547 nondiabetic adults (>18 years of age) without a history of myocardial infarction ...

Diagnosis, Prognosis, and Treatment of Impaired Glucose Tolerance and Impaired Fasting Glucose

Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) are the intermediate metabolic states between normal and diabetic glucose homeostasis. These conditions are thought to be the precursors of DM, but the progression to overt disease is not straightforward. The risk for both macrovascular and microvascular complications increases across the distribution of blood glucose concentra...

Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.

Impaired glucose tolerance, impaired fasting glucose and cardiovascular risk.

To the Editor: Tamita et al reported that abnormal glucose tolerance in patients with acute myocardial infarction (AMI) is a major risk factor for future cardiovascular events and might critically distinguish high-risk individuals.1 The cardiovascular event-free survival rate in the impaired glucose tolerance (IGT) group and the group with newly diagnosed diabetes were 73% and 67%, respectively...